494: What is the prognostic value of a normal adenosine myocardial perfusion imaging in cardiac transplant patients?

epicardial CAV. For these 24 patients, 5-year survival after re-transplantation was 70.8%, which is comparable to survival of the 7 re-transplant patients with severe systolic dysfunction. Conclusions: Retransplantation in patients with severe heart failure symptoms but preserved systolic function (similar to restrictive cardiomyopathic patients) appears acceptable. These patients have comparable survival to patients re-transplanted due to systolic dysfunction and therefore, should be considered candidates for re-transplantation. 494